StockData
Pluri Inc. logo

Pluri Inc. (PLUR) stock

PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.92−0.06 (-6.62%)

Close on Nov 18, 2026Market cap $11.30MP/E –Yield –

Pluri price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Pluri's price to sales ratio was 12.8× on Nov 11, 2026, against 23.2× a year earlier. Over the last 5 years it ranged from 10.7× to 236.1×, with a median of 45.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202612.8×−5.6
2025Dec 31, 202518.4×−21.0
2024Dec 31, 202439.4×−55.2
2023Dec 29, 202394.6×−2.7
2022Oct 31, 202297.2×+53.5
2016Oct 31, 201643.7×−192.4
2015Dec 31, 2015236.1×−222.9
2014Dec 31, 2014459.0×+95.1
2013Dec 31, 2013363.9×+16.8
2012Dec 31, 2012347.1×–

More Pluri figures

See a number that looks wrong?